Axsome Therapeutics, Inc. - Common Stock —— 资产负债表 (NASDAQ:AXSM) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 186.13 M87.79 M331.48 M588.24 M568.5 M689.8 M 负债总额 72.34 M72.15 M221.92 M397.26 M511.48 M601.51 M 权益总额 113.79 M15.63 M109.56 M190.98 M57.02 M88.3 M 负债及股东权益总额 186.13 M87.79 M331.48 M588.24 M568.5 M689.8 M 总债务 48.32 M49.09 M94.26 M178.07 M180.71 M190.29 M 净债务 48.32 M49.09 M94.26 M178.07 M180.71 M-205.19 M

新闻

Axsome's Auvelity: A New Treatment For Agitation In Alzheimer's Disease (AXSM)

Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders

Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Carillon Chartwell Small Cap Growth Fund: Q1 2026 Portfolio Movers

Axsome Therapeutics, Inc. (AXSM) Q1 2026 Earnings Call Transcript

Axsome Therapeutics Q1 2026 Earnings Review: Gains Mystify Me, But Can't Be Denied (AXSM)

Here's What Key Metrics Tell Us About Axsome (AXSM) Q1 Earnings

Axsome Continues Its Breakneck Pace On Solid First-Quarter Sales

Axsome Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:AXSM) 2026-05-04

Axsome Therapeutics (AXSM) Reports Q1 Loss, Beats Revenue Estimates

Market Week Ahead: Is May A Good Month For The Stock Market?